Should You Consider Regeneron (REGN) Ahead of Q1 Earnings?

AbbVie (ABBV) Beats on Q1 Earnings & Sales, Ups '24 EPS View

Roche (RHHBY) Q1 Hit by Currency Headwinds, Lower COVID-19 Sales

Novartis (NVS) Q1 Earnings, Sales Beat, Guidance Raised

Roche (RHHBY) Alecensa Wins FDA Nod for Label Expansion

Pharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data

Adaptimmune (ADAP) Down on End of Collaboration With Roche

Roche's (RHHBY) Combination Therapy Meets Goal in Lymphoma Study

Regeneron (REGN) Accused of Fraudulent Practices Related to Eylea

ALX Oncology (ALXO) Posts Upbeat Results From Lymphoma Study

Syros (SYRS) Up on FDA Fast Track Tag for Tamibarotene in AML

Nurix (NRIX) Up on Upbeat Initial Data From Phase I Cancer Study

Genprex (GNPX) Expands SCLC Study of Key Candidate, Stock Up

Viking (VKTX) Up 17% on Encouraging Oral Obesity Drug Data

Why Argenx's (ARGX) Stock Price Moved Up 11% on Thursday

PTC Therapeutics (PTCT) Up on Positive Regulatory Updates

Roche (RHHBY) Launches AI-Based Predictive CGM Accu-Chek

Pharma Stock Roundup: NVO's New Obesity Pill Data, RHHBY, AZN's Pipeline Updates

Alnylam (ALNY), Roche's Blood Pressure Drug Meets Study Goal